Neoleukin Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NLTX and other ETFs, options, and stocks.

About NLTX

Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. 

CEO
Jonathan G. Drachman
CEOJonathan G. Drachman
Employees
91
Employees91
Headquarters
Seattle, Washington
HeadquartersSeattle, Washington
Founded
2003
Founded2003
Employees
91
Employees91

NLTX Key Statistics

Market cap
21.30M
Market cap21.30M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
336.23K
Average volume336.23K
High today
$0.50
High today$0.50
Low today
$0.50
Low today$0.50
Open price
$0.45
Open price$0.45
Volume
500.00
Volume500.00
52 Week high
$5.76
52 Week high$5.76
52 Week low
$0.375
52 Week low$0.375

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
0%
Sell
14.3%

NLTX Earnings

-$0.30
-$0.20
-$0.10
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 1, After Hours
ActualExpected Mar 1, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.